MOTS-c

People run it for fat loss, steadier energy, and better insulin sensitivity — a metabolic “tune-up,” especially for anyone feeling the early slide into insulin resistance with age. The reported wins are improved glucose handling, easier fat-burning, and less afternoon crash. It is not an appetite drug: unlike the GLP-1 class, it works by helping cells use fuel, not by shutting down hunger.

It’s encoded inside your mitochondria, not your nuclear DNA — a signal your cells already release when you exercise. Injecting more of it essentially turns up that same “you’re working out” message: it activates AMPK, boosts GLUT4 glucose uptake, and pushes cells toward burning fat for fuel. That’s why it’s called an exercise mimetic — and why the loudest, most honest theme in the community is that it works with movement, sauna, and physical stress, and goes quiet without them. People on a testosterone cycle often report it feeling “useless,” because the metabolic problem it fixes is already being handled.

A mitochondrial-derived peptide that acts as a metabolic stress signal. It activates the AMPK pathway — the cell’s low-fuel sensor — which upregulates GLUT4-mediated glucose uptake (letting cells pull in sugar with less insulin), shifts metabolism toward fat oxidation, and supports mitochondrial function under stress. Crucially, it’s the same pathway exercise triggers, which is the mechanistic basis for both the “exercise mimetic” label and the fact that it stacks with exercise rather than substituting for it. Peripherally injected, it does not meaningfully cross the blood–brain barrier, so any “focus/mood” claims are indirect at best.

Generally reported as mild. The most consistent is injection-site irritation — redness, swelling, soreness — which usually settles. Beyond that the picture is split: some people get the energy they came for, while others report the opposite — fatigue, lethargy, or disrupted sleep — and the common fix is to drop to a daily microdose or cycle off. A minority mention jitteriness, palpitations, or insomnia. Because there’s no real human safety trial for the way it’s used, the honest framing is that the side-effect picture is community-reported, not characterized — and one research thread flags a pro-diabetogenic context that complicates the tidy “longevity peptide” story.

The real “stack” is exercise — that’s the pairing that makes it work, and the community is unusually unanimous on it. Among peptides, it’s most often run alongside SS-31, the other mitochondrial peptide, on the logic that one repairs mitochondria while the other signals them to work harder. Some pair it with fat-loss or recovery compounds, but the foundation people keep returning to isn’t another vial — it’s training, sauna, and a reason for the cell to respond.